We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$79.7B
AUM Growth
-$2.55B
Cap. Flow
-$8.09B
Cap. Flow %
-10.15%
Top 10 Hldgs %
26.07%
Holding
2,483
New
414
Increased
840
Reduced
685
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Financials 13.95%
3 Healthcare 12.34%
4 Industrials 9.8%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGI icon
2226
Selective Insurance
SIGI
$5.65B
-1,228
Closed -$134K
SIRI icon
2227
SiriusXM
SIRI
$9.98B
-2,300
Closed -$89K
SJT
2228
San Juan Basin Royalty Trust
SJT
$117M
-17,422
Closed -$92K
SLDB icon
2229
Solid Biosciences
SLDB
$794M
$0 ﹤0.01%
149
-1,480
-91% -$13.3K
SNX icon
2230
TD Synnex
SNX
$20.4B
-10
Closed -$1K
SON icon
2231
Sonoco
SON
$5.57B
-2,111
Closed -$122K
SPRO icon
2232
Spero Therapeutics
SPRO
$67.7M
-1,248
Closed -$2K
SRCE icon
2233
1st Source
SRCE
$2.16B
-820
Closed -$42K
SSL icon
2234
Sasol
SSL
$7.5B
-35,300
Closed -$275K
SSTK icon
2235
Shutterstock
SSTK
$198M
-1,414
Closed -$64K
STAA icon
2236
STAAR Surgical
STAA
$1.21B
-31
Closed -$1K
STE icon
2237
Steris
STE
$22.3B
-3
Closed
STNE icon
2238
StoneCo
STNE
$2.77B
-2,520
Closed -$41K
STRO icon
2239
Sutro Biopharma
STRO
$401M
-1,639
Closed -$92K
SWIM icon
2240
Latham Group
SWIM
$629M
-20,421
Closed -$80K
SWK icon
2241
Stanley Black & Decker
SWK
$14.3B
$0 ﹤0.01%
+8
New +$704
TCRX icon
2242
TScan Therapeutics
TCRX
$48.6M
$0 ﹤0.01%
176
-2,375
-93% -$18.7K
THRY icon
2243
Thryv Holdings
THRY
$180M
-5,320
Closed -$118K
TLS icon
2244
Telos
TLS
$332M
-14,094
Closed -$58K
TNGX icon
2245
Tango Therapeutics
TNGX
$4.43B
$0 ﹤0.01%
98
-2,251
-96% -$17.4K
TNYA icon
2246
Tenaya Therapeutics
TNYA
$161M
$0 ﹤0.01%
217
-3,137
-94% -$13K
TRUE
2247
DELISTED
TrueCar
TRUE
-12,894
Closed -$43K
TSHA icon
2248
Taysha Gene Therapies
TSHA
$1.68B
$0 ﹤0.01%
366
-5,438
-94% -$15.8K
TWIN icon
2249
Twin Disc
TWIN
$329M
$0 ﹤0.01%
76
-98
-56% -$1.45K
U icon
2250
Unity
U
$13.8B
$0 ﹤0.01%
57
-2,950
-98% -$63.1K

Similar funds

Lazard Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Lazard Asset Management held 2,483 positions worth $79.7B, down 3.1% from $82.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $8.09B in Q2 2024, closing 192 positions and reducing 685 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $206M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Aspen Technology Inc worth $105M.

  • Lazard Asset Management's largest Q2 2024 buy was Aspen Technology Inc: 526,997 shares worth $105M.
  • Lazard Asset Management added most to ExxonMobil in Q2 2024, an estimated $892M increase.
  • Lazard Asset Management's biggest Q2 2024 reduction was Chevron, cutting an estimated $812M.
  • Lazard Asset Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $206M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $79.7B portfolio in Q2 2024.
  • Lazard Asset Management opened 414 new positions and closed 192 in Q2 2024.
  • Lazard Asset Management's portfolio value fell 3.1% quarter-over-quarter to $79.7B.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.